Menopause Might Become Optional for Women
What: New tech and drugs like rapamycin aim to extend ovarian function.
Key Line: “You want to extend normal heart function… but slowing ovarian aging touches a very different note.”
State attempts to expand fertility coverage face opposition from cost and fetal personhood movements.
New research finds minor, temporary changes in menstrual cycle length post-vaccine.
Guardian report details how U.S. medical trainees are seeking abortion education abroad.
NIH insists WHI is funded, but federal contract officers haven’t been told.
Healthier childhood diets—not body size—linked to later menstruation.
Science reports the entire CDC team behind contraceptive safety guidelines has been ousted.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
The Guardian reviews how “fetal personhood” laws could criminalize abortion patients.
Interleukin-6 shows early promise in detecting life-threatening sepsis.
The influential Women’s Health Initiative will shut down without federal support.
Survey shows vast majority of women feel unprepared for menopause.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
Women with endometriosis are more likely to face earlier surgical or natural menopause.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
The Economist finds abortions have increased in some states *after* bans, thanks to telehealth and shield laws.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
Yale study shows women in Southern states barely gained life expectancy over 100 years.